Management of Intracerebral Hemorrhage in a Patient with CKD-Induced
Hypertension
1. Introduction
Chronic kidney disease (CKD) and hypertension share a bidirectional relationship. CKD
predisposes to hypertension through mechanisms such as volume overload, activation of
the renin–angiotensin–aldosterone system (RAAS), and increased sympathetic tone. Over
time, uncontrolled hypertension damages cerebral small vessels, increasing the risk of
intracerebral hemorrhage (ICH/IPH). Managing such patients requires balancing cerebral
perfusion goals with renal protection.
2. Pathophysiological Link: CKD → HTN → IPH
In CKD, impaired sodium excretion leads to fluid retention and elevated systemic vascular
resistance. RAAS activation further increases afterload, while uremic toxins cause
endothelial dysfunction and vascular stiffness. Chronic hypertension weakens small
perforating cerebral arteries (particularly in basal ganglia, thalamus, pons), predisposing to
rupture under pressure spikes.
3. Clinical Presentation
Patients usually present with sudden focal neurological deficits (hemiplegia, dysarthria,
altered sensorium) and often with severely elevated BP. CKD patients may have
accompanying uremic symptoms (nausea, vomiting, confusion).
4. Emergency Department Approach – First Hour
• Ensure airway, breathing, and circulation.
• Position patient 30° head-up.
• Obtain IV access and monitor ECG, BP, SpO₂.
• Send immediate labs: CBC, renal panel, electrolytes, glucose, coagulation profile.
• Non-contrast CT brain within 20 minutes to confirm IPH.
• Avoid aggressive BP reduction initially — aim for smooth, controlled lowering.
5. Blood Pressure Management
Target depends on initial BP and neurological status:
- If SBP > 220 mmHg: reduce by 15% in first hour.
- If 140–220 mmHg: lower to 140 mmHg gradually.
Preferred drugs in CKD:
• IV labetalol (0.2–0.3 mg/kg bolus, repeat as needed)
• IV nicardipine infusion (start 5 mg/h, titrate)
Avoid nitroprusside (cyanide toxicity risk in CKD).
Monitor for hypotension which may worsen cerebral perfusion.
6. Fluid and Electrolyte Balance
Avoid hypotonic or glucose-containing fluids. Use isotonic saline cautiously. Correct
hyponatremia slowly to avoid osmotic demyelination. Monitor potassium closely — both
uremia and ACEI/ARB use predispose to hyperkalemia.
7. Dialysis Considerations
Indications for urgent dialysis:
• Volume overload not responding to diuretics.
• Severe hyperkalemia (>6.5 mmol/L).
• Metabolic acidosis (pH < 7.1).
• Uremic encephalopathy.
Avoid rapid osmotic shifts during dialysis (use slower, low-flow settings). Coordinate with
nephrology.
8. Intracranial Pressure (ICP) Management
• Head elevation 30°.
• Maintain normocapnia (PaCO₂ 35–40 mmHg).
• IV mannitol (0.25–0.5 g/kg) can be used cautiously if not anuric.
• Hypertonic saline (3%) preferred in oliguric/anuric CKD.
• Avoid fluid overload.
9. Seizure Control
CKD patients may accumulate antiepileptic drugs; dose adjust levetiracetam, valproate.
Prophylaxis usually not needed unless cortical bleed or seizure occurs.
10. Hemostatic and Reversal Strategies
If on antiplatelets: consider desmopressin (0.3 µg/kg IV).
If on anticoagulants: reverse warfarin with PCC + vitamin K; reverse DOACs with specific
antidotes.
Platelet transfusion if count <100,000/mm³ with ongoing bleed.
11. Surgical Management
Indicated for large lobar hematomas (>30 mL), cerebellar bleeds causing brainstem
compression, or progressive neurological decline.
In CKD, pre-op optimization includes correction of anemia, uremia, and platelet dysfunction.
12. BP Control in Subacute Phase
After stabilization, maintain SBP 130–150 mmHg.
Long-term antihypertensives: calcium channel blockers, beta-blockers, or RAAS blockers (if
tolerated). Avoid aggressive diuresis unless volume overloaded.
13. Secondary Prevention
• Strict BP control (<130/80 mmHg).
• Treat dyslipidemia, anemia, and metabolic acidosis.
• Low-salt diet (<2 g/day sodium).
• Regular nephrology + neurology follow-up.
• Evaluate for secondary causes of hypertension.
14. Rehabilitation and Long-term Care
Multidisciplinary care — physiotherapy, speech therapy, and nutritional counseling.
Monitor for depression and cognitive decline.
Regular BP, renal function, and medication adherence checks.
15. Case Example 1 – Emergency Management
A 58-year-old male with CKD stage 4 presents with right-sided weakness, BP 230/130. CT
brain shows left thalamic hemorrhage. Managed with IV labetalol, gradual BP reduction,
mannitol avoided (oliguria), hypertonic saline used. Dialysis done on day 2 due to
hyperkalemia and volume overload.
16. Case Example 2 – Dialysis Timing Dilemma
A 65-year-old female on maintenance HD develops sudden LOC. CT shows putaminal bleed.
Dialysis deferred 24 h, resumed with slow low-flow settings to avoid cerebral edema.
17. Flowchart – Initial Management
1. ABC stabilization
2. Urgent CT brain
3. Controlled BP lowering
4. Evaluate for dialysis need
5. ICP management
6. Multidisciplinary coordination
18. Flowchart – Dialysis Timing Decision
Assess uremic symptoms → Evaluate volume status → Check K+, pH → If urgent, initiate
modified low-flow dialysis → Avoid rapid osmotic correction.
19. Prognosis
Mortality is higher in CKD due to poor autoregulation, platelet dysfunction, and limited
medication options. Early BP control and avoidance of osmotic shifts improve survival.
20. Key Takeaways
• CKD and HTN synergistically increase IPH risk.
• Control BP smoothly; avoid nitroprusside.
• Prefer hypertonic saline over mannitol if oliguric.
• Coordinate neuro and nephro management closely.
• Post-stabilization: strict BP, renal care, and rehabilitation.
